Literature DB >> 8640837

Gene expression of neural cell adhesion molecule L1 in malignant gliomas and biological significance of L1 in glioma invasion.

S Izumoto1, T Ohnishi, N Arita, S Hiraga, T Taki, T Hayakawa.   

Abstract

Neural cell adhesion molecule L1 is a member of the immunoglobulin superfamily that is expressed in the nervous system. Its functions have been mainly studied in vitro using premature neuronal cells. We show that all glioma cells tested, as well as normal glia cells, express a short type of L1, L1cs mRNA. The expression of L1 protein in glioma cells was confirmed by Western blotting and flow cytometric analysis. Migration assay showed that C6 glioma cells were stimulated to migrate to soluble L1 and L1cs released from L1- or L1cs-transfected fibroblast cells. The L1-stimulated migration was significantly inhibited by antibody that recognizes the immunoglobulin C2-like domain of L1. However, antibodies that recognize the fibronectin type III-like domain and the cytoplasmic (IC) domain of L1 had no effect on migration. Our in vivo migration study demonstrated the migration of L1 on C6 glioma cells that had been transfected in rat brains. These results suggest that L1cs expressed on glioma cells may play an important role in the adhesion and migration of glioma cells by homophilic binding (probably through the extracellular immunoglobulin C2 domain of L1) and that L1cs participates in tumor invasion along neuronal fibers.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8640837

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  34 in total

1.  Human and rat glioma growth, invasion, and vascularization in a novel chick embryo brain tumor model.

Authors:  Alexandra Cretu; Joseph S Fotos; Brian W Little; Deni S Galileo
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

2.  Targeting cancer stem cells through L1CAM suppresses glioma growth.

Authors:  Shideng Bao; Qiulian Wu; Zhizhong Li; Sith Sathornsumetee; Hui Wang; Roger E McLendon; Anita B Hjelmeland; Jeremy N Rich
Journal:  Cancer Res       Date:  2008-08-01       Impact factor: 12.701

3.  Mutant-IDH1-dependent chromatin state reprogramming, reversibility, and persistence.

Authors:  Sevin Turcan; Vladimir Makarov; Julian Taranda; Yuxiang Wang; Armida W M Fabius; Wei Wu; Yupeng Zheng; Nour El-Amine; Sara Haddock; Gouri Nanjangud; H Carl LeKaye; Cameron Brennan; Justin Cross; Jason T Huse; Neil L Kelleher; Pavel Osten; Craig B Thompson; Timothy A Chan
Journal:  Nat Genet       Date:  2017-11-27       Impact factor: 38.330

4.  Inhibition of glioma cell proliferation by neural stem cell factor.

Authors:  Tsuyoshi Suzuki; Shuichi Izumoto; Kouichi Wada; Yasunori Fujimoto; Motohiko Maruno; Mami Yamasaki; Yonehiro Kanemura; Takuya Shimazaki; Hideyuki Okano; Toshiki Yoshimine
Journal:  J Neurooncol       Date:  2005-09       Impact factor: 4.130

5.  Neural cell adhesion molecule L1 in gliomas: correlation with TGF-beta and p53.

Authors:  T Tsuzuki; S Izumoto; T Ohnishi; S Hiraga; N Arita; T Hayakawa
Journal:  J Clin Pathol       Date:  1998-01       Impact factor: 3.411

Review 6.  Advances in chimeric antigen receptor immunotherapy for neuroblastoma.

Authors:  Andras Heczey; Chrystal U Louis
Journal:  Discov Med       Date:  2013-12       Impact factor: 2.970

7.  Massively parallel signature sequencing and bioinformatics analysis identifies up-regulation of TGFBI and SOX4 in human glioblastoma.

Authors:  Biaoyang Lin; Anup Madan; Jae-Geun Yoon; Xuefeng Fang; Xiaowei Yan; Taek-Kyun Kim; Daehee Hwang; Leroy Hood; Gregory Foltz
Journal:  PLoS One       Date:  2010-04-19       Impact factor: 3.240

8.  Poliovirus receptor CD155-targeted oncolysis of glioma.

Authors:  Melinda K Merrill; Guenter Bernhardt; John H Sampson; Carol J Wikstrand; Darell D Bigner; Matthias Gromeier
Journal:  Neuro Oncol       Date:  2004-07       Impact factor: 12.300

9.  Cancer genomics identifies regulatory gene networks associated with the transition from dysplasia to advanced lung adenocarcinomas induced by c-Raf-1.

Authors:  Astrid Rohrbeck; Jürgen Borlak
Journal:  PLoS One       Date:  2009-10-08       Impact factor: 3.240

10.  Stimulation of glioma cell motility by expression, proteolysis, and release of the L1 neural cell recognition molecule.

Authors:  Muhua Yang; Shalini Adla; Murali K Temburni; Vivek P Patel; Errin L Lagow; Owen A Brady; Jing Tian; Magdy I Boulos; Deni S Galileo
Journal:  Cancer Cell Int       Date:  2009-10-29       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.